Stock Code: 002399 Stock Abbreviation: Hepalink Announcement No.: 2026-019 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Announcement on Holding the 2025 Annual Performance Briefing The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") disclosed its "2025 Annual Report" and its summary on the Juchao Information Network on March 31, 2026. To help investors gain a more comprehensive and in-depth understanding of the Company's operating performance, development strategies, and other aspects, the Company w
002399SZSE
Announcement on Holding the 2025 Annual Performance Briefing
✨ AI Summary
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. will hold its 2025 Annual Performance Briefing on April 20, 2026, from 15:00 to 16:30. The briefing will be conducted online via "Value Online" (www.ir-online.cn) to facilitate investor communication and feedback. Key company executives will attend to discuss performance and strategy. Investors can submit questions in advance.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· gemini_document
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.